GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Median Diagnostics Inc (XKRX:233250) » Definitions » ROC %

Median Diagnostics (XKRX:233250) ROC % : 5.12% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Median Diagnostics ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Median Diagnostics's annualized return on capital (ROC %) for the quarter that ended in Dec. 2024 was 5.12%.

As of today (2025-03-15), Median Diagnostics's WACC % is 3.86%. Median Diagnostics's ROC % is 5.12% (calculated using TTM income statement data). Median Diagnostics generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Median Diagnostics ROC % Historical Data

The historical data trend for Median Diagnostics's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Diagnostics ROC % Chart

Median Diagnostics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.00 18.38 2.10 -10.17 5.12

Median Diagnostics Semi-Annual Data
Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.00 18.38 2.10 -10.17 5.12

Median Diagnostics ROC % Calculation

Median Diagnostics's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2024 is calculated as:

ROC % (A: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2023 ) + Invested Capital (A: Dec. 2024 ))/ count )
=423.504 * ( 1 - -51.22% )/( (12181.84 + 12824.114)/ 2 )
=640.4227488/12502.977
=5.12 %

where

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=21723.872 - 792.012 - ( 8750.02 - max(0, 2419.423 - 13698.446+8750.02))
=12181.84

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=22664.488 - 570.211 - ( 9270.163 - max(0, 1786.204 - 14476.916+9270.163))
=12824.114

Median Diagnostics's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=423.504 * ( 1 - -51.22% )/( (12181.84 + 12824.114)/ 2 )
=640.4227488/12502.977
=5.12 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=21723.872 - 792.012 - ( 8750.02 - max(0, 2419.423 - 13698.446+8750.02))
=12181.84

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=22664.488 - 570.211 - ( 9270.163 - max(0, 1786.204 - 14476.916+9270.163))
=12824.114

Note: The Operating Income data used here is one times the annual (Dec. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Median Diagnostics  (XKRX:233250) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Median Diagnostics's WACC % is 3.86%. Median Diagnostics's ROC % is 5.12% (calculated using TTM income statement data). Median Diagnostics generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Median Diagnostics ROC % Related Terms

Thank you for viewing the detailed overview of Median Diagnostics's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Median Diagnostics Business Description

Traded in Other Exchanges
N/A
Address
878 Seoul Office, Dongnae-dong, Kangwon-do, Chuncheon, KOR, 200-883
Median Diagnostics Inc is a Korea based company engaged in providing IVD solutions and veterinary diagnostics services. Its solutions portfolio covers avian influenza diagnosis solution, foot and mouth disease diagnosis solution, African Pig fever solution and others. The company offers ELISA diagnostic products, rapid test kit, molecular diagnosis products, standard diagnosis products and biologicals.

Median Diagnostics Headlines

No Headlines